Introduction: The 5-fluorouracile (5FU) + dacarbazine (DTIC) combination has been poorly evaluated in NET
Aim(s): To assess the efficacy and safety of 5FU-DTIC and to explore potential predictive factors of efficacy
Materials and methods: Medical and imaging records of all consecutive patients (pts) with metastatic well-differentiated pancreatic (p) or small intestine (si) NET receiving 5FU-DTIC between 2004 and 2015 in 3 expert centres were retrospectively reviewed. Tumor expression of DAXX, ATRX, MGMT and APNG was centrally performed
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Medical treatment – Chemotherapy, medical treatment - others
Presenting Author: Dr Louis de Mestier
To read results and conclusion, please login ...
Further abstracts you may be interested in